CKD/Renovascular Hypertension Flashcards

1
Q

Chronic Kidney Disease

general

A

15% of all Americans have CKD
Abnormal kidney function > 3 months

Usually asymptomatic until near end stage
Primary cause is DM, HTN, ASCVD
Progressive decline in kidney function

CKD is independent risk factor for CAD
Proteinuric CKD is ominous- worse prognosis
Most patient stage 3 CKD die from ASCVD before ESRD
Abnormal kidney function: GFR < 60mL/min or proteinuria, albuminuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CKD

Abnormal renal studies

A

> 3 months
Elevated BUN
Elevated Creatinine
Albumin in urine
Elevated UACR
Cystatin C
RBC or WBC casts; broad waxy casts seen in ESRD
Trending labs is very important, especially stage I and II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

CKD

RF

A

Diabetes mellitus
Hypertension
Chronic NSAID use
Glomerulonephritis
Polycystic kidney disease
Systemic Lupus Erythematous
Hx Kidney transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Chronic Kidney Disease

Causes

A

Diabetes mellitus, hypertension, glomerulonephritis, polycystic kidney disease, SLE, nephrotoxins, multiple myeloma, HIV, chronic pyelonephritis, renal artery stenosis, nephrolithiasis, prostate disease, neurogenic bladder
* hx of previous AKI ( esp within 1 year) increases risk of another AKI event/ CKD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CKD

Symptoms

A

Fatigue, malaise, anorexia, nausea, vomiting, metallic taste, hiccups, DOE, irritability, muscle cramps, restless legs, weakness, pruritis, easy bruising, altered mentation

  • Stages I-IV asymptomatic!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CKD

Physical exam

A

Weight loss, edema, muscle wasting, pallor, ecchymosis, bruit
Arterial narrowing and AV nicking seen in early HTN while flame hemorrhages seen later; papilledema occurs when there is increased intracranial pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CKD

Labs

A

BMP: electrolytes, bun, creatinine; Calculation of GFR (Cockcroft gault formula vs MDRD)

Urinalysis: proteinuria, albuminuria; spot UACR

Urine microscopy: waxy casts

CBC: anemia

Other: PTH, vitamin D, Ca, phosphate, lipids, Hgb, Mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CKD

imaging/dx

A

Ultrasound: reduced renal cortical thickness < 6mm’ small, echogenic kidney BIL

Biopsy: only when suspect glomerular or tubulointerstitial disease; risk is important to consider; risk increases if kidney < 9 cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CKD

Tx and goals

A

ACE-I and ARBS
BP control < 130/80 ( ACC/AHA/ADA) < 120/80 (KDIGO)

HgA1c < 7.0, LDL < 100 mg/dL, HDL > 50 mg/dL, Triglycerides < 150 mg/dL; Hgb 11-12 g/dL
Statins if > 50 yoa (non-hemodialysis patients) MIT

SGLT-2 (GFR > 20)
GLP-1 (additional cardiovascular risk reduction; DKD)
Non-MRA (if DKD) : Finerenone (Kerendia)

Avoid nephrotoxic drugs
Restricted protein, Na ( < 1.5 g) K diet- poss Ca and Vit D supplement

Dc tobacco, weight control
Vaccinations: Pneumococcal, HBV, influenza, COVID-19
Hemodialysis
Kidney transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CKD

A

green is for DM II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CKD pearls

In patients with CKD pay attention to Rx!!! Do NOT want to cause an AKI and renal function is very dynamic

A

Antibiotics:
Augmentin : avoid 875mg with CrCl< 30; use 250-500 mg
Amoxicillin: 250-500 mg po q 12 if CrCl< 30
Doxycycline: requires no dose adjustment
Azithromycin: requires no dose adjustment
Clindamycin: requires no dose adjustment
Clarithromycin: reduce dose by 50% if CrCl<30
Ciprofloxacin: reduce 500 mg q 24 hours CrCl < 30
Levaquin: reduce dose to q 48 hours CrCl < 50
Bactrim: reduce usually dose 50% CrCl <30
Nitrofurantoin: contraindicated GFR < 60?
Metronidazole: adjust CrCl< 10
Cephalexin

Tamiflu

Gout
Allopurinol: reduce 50 mg daily CrCl < 60
Colchicine: avoid GFR , 30
Indomethacin: avoid GFR < 60
*drug of choice for gout flare if CKD GFR < 30 is prednisone ( no dose adjustment)

Pain Control
Meloxicam: reduce CrCl < 20
Ibuprofen: avoid GFR < 60
Naproxen: avoid GFR < 30
Percocet: reduce dose q 12 if GFR < 30
Tylenol with codeine: no adjustment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CKD

Refer to nephro when

A

GFR < 30 mL /min
UACR > 300mg/g
Urine
Protein/creatinine ratio > 500 mg/g

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CKD

Annual screenings

A

Diabetes Mellitus
Hypertension
Coronary artery disease
Age >
Obesity
Family hx CKD
Polycystic kidney disease
Systemic lupus erythematous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CKD

SCREENING TESTS

A

Screening for CKD includes measurement of serum creatinine, estimation of GFR using a serum creatinine-based equation, measurement of the urine albumin/creatinine ratio, and urinalysis.

Urinalysis has a high sensitivity for heavy proteinuria (greater than 300 mg per 24 hours, as estimated from the spot urine protein/creatinine ratio) but may not detect clinically significant lower levels (30 to 300 mg).

Because albumin is the predominantly filtered glomerular protein, initial proteinuria evaluation using the spot urine albumin/creatinine ratio obtained from an early morning sample is recommended

Timed 24-hour urine collections are no longer recommended as an initial diagnostic tool because of the potential for inadequate collection, inconvenience to patients, and the lack of diagnostic advantage over the urine albumin/creatinine ratio.- AAFP.org

not sure if this matters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CKD stage 1 - IV
Tx and goals

A

Yearly BMP, UACR, Lipids
BP < 120/80 ( ace/arb); NA < 1.5 g daily
Statin: moderate intensity pts > 50 yoa GFR < 60ml/min
Low dose asa if low bleeding risk?
Current vaccinations
Remember risk for ASCVD!!!

17
Q

CKD stage III and IV
Monitoring

A

Yearly BMP, UACR, Lipids, PTH, calcium, Vitamin D, CBC, phosphorus

18
Q

Complications of stage IV/V CKD

A

Anemia: decreased erythropoietin production
Check iron levels first! If therapeutic, consider erythropoietin
* use the lowest dose of erythropoietin possible as increases ASCVD risk
The goal is to maintain Hgb > 11 g/D
low iron may start on oral with Ferrous sulfate or give IV

Hyperkalemia
Dietary counseling; avoidance ACE-I/ARB; Spironolactone
K binding agents: sodium polystyrene sulfonate ( kayexalate), sodium zirconium cyclosilicate (Lokelma), patiromer ( Veltassa)

Acidemia
Consistent serum bicarbonate < 20 mEq/dl
Oral bicarbonate solution/tablets- weight based
caution with oral bicarbonate replacement as cause increase fluid retention leading to HTN and edema

Secondary hyperparathyroid
Develops in response to low Ca++
Calcitriol, paricalcitol, deoxercalciferol
Goal PTH 150-300pg/mL

Elevated phosphorus
Dietary modification
renal osteodystrophy: low Ca+ high Phosphate+ elevated PTH: pathological fractures
Oral phosphate binders with meals: calcium carbonate or calcium acetate if calcium is not elevated; sevelamer (Renagel) if elevated Calcium and phosphate levels
Phosphate goal < 5.5

Hypocalcemia
Decreased calcitriol horomone thus decreased reabsorption of ca in nephrons and gi tract
Leads to bone break down and osteoporosis-
Oral calcium carbonate or calcium acetate 550 mg -1 g TID with meals

Low vitamin D
Oral replacement tx
Ergocalciferol if vitamin D < 30ng/mL

19
Q

Complications of stage IV/V CKD

Renal Osteodystrophy

A

Osteitis fibrosa cystica
Osteomalacia
Presentation: pathologic fractures, chondrocalcinosis, bone and proximal muscle pain

20
Q

CKD- Renal Osteodystrophy

Labs and imaging

A

Diagnosis:
Labs: elevated PTH, hypoCa, elevated phosphate
Xray: periosteal erosions, bony cysts ( thin trabeculum and cortex), punctate trabecular bone resorption in skill ( “salt and pepper” skull)

21
Q

CKD- Renal Osteodystrophy

Tx

A

Phosphate binders (calcium carbonate, calcium acetate, sevelamer) goal Phosphate < 5.5
Supplement Vit D ( calcitriol ) and calcium
Cinacalcet (decreased PTH)

22
Q

CKD

Vascular Calcifications

A

CKD patients have increase in arterial calcifications which reduces vascular compliance contributing to left ventricular hypertrophy
Increases CVD risk

*Sevelamer- use if elevated CA and Phosphate

23
Q

Chronic Kidney Disease “no no’s”

A

NSAIDS, COX-2
Proton pump inhibitors ( in CKD 4 or later)
Magnesium-containing antacids (tums, Rolaids, Gaviscon, Alka-seltzer)
IV contrast dye
Rx: aminoglycoside, vancomycin, trimethoprim/sulfamethoxazole
Digoxin
Over the counter: magnesium citrate!!!

when GFR < 30 caution will most medications- (metformin, sulfonylureas, ace/arb, HCTZ, DOAC, fenofibrates, lovenox)

Want to prevent AKI on CKD

24
Q
A
25
Q

Special Population with CKD

A

Children
Should have yearly FLP
If elevated lipids and < 18 yoa start with TLCs prior to Rx intervention
HD patient
Continue statin if on pre-HD or indicated for other diagnosis
Do not start statin on HD patient unless otherwise indicated

26
Q

Renovascular Hypertension

general

A

High blood pressure which develops secondary to renal artery disease either renal artery stenosis ( 90%) or fibromuscular dysplasia

27
Q

Renal Artery Stenosis

General / clin man/ tx

A

Older patient w ascvd
Smoking or ascvd risk factors
Located aortic orifice or proximal main renal artery

Presentation:
HTN refractory to rx, AKI post starting ACE/ARB, abdominal brut

Workup:
imaging with ultrasound, CTA, MRA, renal angiography gold standard

Treatment:
PCTA/stent or bypass

28
Q

Fibromuscular dysplasia

General / clin man/ dx/ tx

A

Younger patient < 50; women
Located distal main renal artery or intrarenal branches

Presentation:
Refractory HTN to Rx; +/- worsening GFR
May hear a bruit in carotid arteries

Work up:
Imaging with doppler, MR< CTA, renal angiography
“string of pearls sign
Have an increased risk for aneurysm – all should have at least a one-time assessment for intracranial aneurysm with brain CT or MRA

Treatment:
PTCA/stent/bypass

29
Q

Renovascular Disease

A
30
Q
A

CKD stages